Simultaneous determination of nintedanib and its metabolite by UPLC–MS/MS in rat plasma and its application to a pharmacokinetic study
Author:
Publisher
Elsevier BV
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference14 articles.
1. BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy;Hilberg;Cancer Res.,2008
2. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis;Richeldi;N. Engl. J. Med.,2014
3. Nintedanib: first global approval;McCormack;Drugs,2015
4. Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis;Wollin;Eur. Respir. J.,2015
5. Nintedanib in the treatment of idiopathic pulmonary fibrosis;Mazzei;Ther. Adv. Respir. Dis.,2015
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development and characterization of nintedanib inhalable powders as a potential pulmonary fibrosis treatment;Journal of Drug Delivery Science and Technology;2024-02
2. Development, stability‐indicating assessment, and evaluation of influential method conditions using a full factorial design for the determination of Nintedanib esylate‐related impurities;Journal of Separation Science;2023-04-12
3. Overview of UHPLC-MS: an Effective and Sensitive Hyphenated Technique;Journal of Analytical Chemistry;2022-11
4. Interpretation of MS–MS spectra of small-molecule signal transduction inhibitors using accurate-m/z data and m/z-shifts with stable-isotope-labeled analogues and metabolites;International Journal of Mass Spectrometry;2021-06
5. QbD Based Development and Validation of RP-HPLC Method for Nintedanib Esylate: Application to Bioanalytical and Stability Study in Plasma;Analytical Chemistry Letters;2021-05-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3